- Home
- GTBP vs BMRA Comparison
GTBP vs BMRA Comparison
Compare GTBP & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- BMRA
- Stock Information
- Founded
- GTBP 1965
- BMRA 1971
- Country
- GTBP United States
- BMRA United States
- Employees
- GTBP N/A
- BMRA N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GTBP Health Care
- BMRA Health Care
- Exchange
- GTBP Nasdaq
- BMRA Nasdaq
- Market Cap
- GTBP 6.6M
- BMRA 7.4M
- IPO Year
- GTBP N/A
- BMRA N/A
- Fundamental
- Price
- GTBP $2.13
- BMRA $0.29
- Analyst Decision
- GTBP Strong Buy
- BMRA
- Analyst Count
- GTBP 1
- BMRA 0
- Target Price
- GTBP $11.00
- BMRA N/A
- AVG Volume (30 Days)
- GTBP 23.9K
- BMRA 2.3M
- Earning Date
- GTBP 11-14-2024
- BMRA 01-14-2025
- Dividend Yield
- GTBP N/A
- BMRA N/A
- EPS Growth
- GTBP N/A
- BMRA N/A
- EPS
- GTBP N/A
- BMRA N/A
- Revenue
- GTBP N/A
- BMRA $5,509,000.00
- Revenue This Year
- GTBP N/A
- BMRA N/A
- Revenue Next Year
- GTBP N/A
- BMRA N/A
- P/E Ratio
- GTBP N/A
- BMRA N/A
- Revenue Growth
- GTBP N/A
- BMRA 1.74
- 52 Week Low
- GTBP $1.92
- BMRA $0.24
- 52 Week High
- GTBP $10.66
- BMRA $1.42
- Technical
- Relative Strength Index (RSI)
- GTBP 40.32
- BMRA 42.21
- Support Level
- GTBP $2.41
- BMRA $0.27
- Resistance Level
- GTBP $3.40
- BMRA $0.48
- Average True Range (ATR)
- GTBP 0.30
- BMRA 0.05
- MACD
- GTBP -0.04
- BMRA -0.00
- Stochastic Oscillator
- GTBP 6.09
- BMRA 10.00
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.